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Abstract
Although various types of stress activate a pituitary
adrenal response, the alteration of endogenous
corticosteroids and catecholamines during asthma
remains unclear. The aim of this study was to assess
changes in endogenous corticosteroid and cate-
cholamine levels in allergic eosinophilic inflammation
in rats, using metabolic cages. Brown Norway rats
(female, 6 weeks old) were sensitized with intraperi-
toneal injections of ovalbumin on days 0 and 2 and
challenged with either an aerosol of ovalbumin or
saline for 30 min on day 21. Levels of urinary 11-
hydroxycorticosteroid (OHCS), a primary metabolite
of corticosterone; epinephrine and norepinephrine
were determined in pooled samples taken 0–24 h
before and 8–32 h after the challenge. Serum adreno-
corticotropic hormone, corticosterone levels and cell
counts in bronchoalveolar lavage fluid were assessed
32–36 h after the challenge, as well as lung eosinophil
peroxidase activity, an indirect index of eosinophil infil-
tration. The numbers of total cells and eosinophils in
bronchoalveolar lavage fluid and lung eosinophil per-
oxidase activity were significantly increased in the
ovalbumin-challenged rats compared with the saline-
challenged rats. While urinary OHCS and serum
corticosterone levels were significantly increased after
challenge in the ovalbumin-challenged rats, com-
pared with the saline-challenged rats (2.1 ± 0.1 ·
10–1 vs 1.7 ± 0.1 · 10–1 mg/g creatinine, P < 0.05
and 482 ± 49 vs 348 ± 19 ng/mL, P < 0.02, respec-
tively), serum adrenocorticotropic hormone levels did
not differ between the two groups. Urinary epinephrine
and norepinephrine excretion also did not differ
between the two groups. It is concluded that endoge-
nous corticosterone, but not catecholamine, increases
as a pathophysiologic adrenal response, possibly to
protect lung during allergic eosinophilic inflammation.
Key words: airway inflammation, asthma, Brown
Norway rat, endogenous corticosteroid, metabolic
cage, urinary catecholamine excretion, urinary 11-
hydroxycorticosteroid excretion.
INTRODUCTION
Asthma is characterized by an increase in airway hyper-
responsiveness to various bronchoconstrictive stimuli and
reversible airway obstruction. The pathogenesis of airway
hyperresponsiveness has been linked to airway inflamma-
tion in human asthma.1 Human asthma is associated with
infiltration of eosinophils and mononuclear cells into the
lungs.2
Clinical investigations have demonstrated that corti-
costeroids are potent inhibitors of the late asthmatic
responses (LAR) in the skin, lung, and nose.3–5 Prevention
and treatment with exogenous corticosteroids are very
effective for reducing airway inflammation, including
eosinophil and T lymphocyte infiltration into the lungs.6
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Endogenous corticosteroids may also be important. For
example, metyrapone, an 11b -hydroxylase inhibitor that
blocks the synthesis of corticosterone, has been found to
enhance airway inflammation in response to an inhaled
allergen in experimental animals.7 Thus, both exogenously
administered and endogenously produced corticosteroids
may down-regulate eosinophilic inflammation.
It is well documented that various types of stress, includ-
ing infection, surgical procedures and inflammation,
activate pituitary-adrenal responses by increasing cyto-
kines and neuropeptides, thereby increasing production
of endogenous corticosteroids and catecholamines in
humans and experimental animals.8,9 However,
Nakazawa et al. and Durham et al. have demonstrated
that serum cortisol levels do not increase during LAR in
human asthma.10,11 Turner et al. have reported that serum
corticosterone levels increase in asthmatic Brown Norway
(BN) rats beyond the normal range reported in the previ-
ous literature;12 however, it seems possible that stresses
other than asthma, including inhalation, handling and
blood sampling, may have increased serum corticos-
terone levels in this study. Because the alteration of
endogenous corticosteroids during eosinophilic inflamma-
tion in asthma is still controversial, it is of interest to assess
pathophysiologic adrenal responses with minimal stress in
a simple experimental model of asthma.
Ovalbumin (OVA)-induced airway eosinophilia and
hyperresponsiveness in the BN rat is a widely used system,
which mimics human asthma in several respects. Patho-
physiologic investigations have revealed a close relation-
ship between antigen-induced infiltration of inflammatory
cells, mostly eosinophils, and either LAR or airway hyperre-
sponsiveness in this model, although the precise underlying
mechanisms are not fully understood.13,14
In the present study, we maintained animals in meta-
bolic cages for assessment of the urinary excretion of
11-hydroxycorticosteroid (OHCS), a primary metabolite
of corticosterone, as well as epinephrine and nor-
epinephrine during airway inflammation in asthmatic BN
rats. In addition, serum adrenocorticotropic hormone
(ACTH) and corticosterone levels were measured as well
as indices of inflammation.
METHODS
Animals
Virus-free, inbred Brown Norway rats (5 weeks old;
Charles River Japan Inc.) were kept in temperature-
controlled rooms under a constant light cycle.
Animals were allowed free access to water and a
standard laboratory diet and the study protocol was
approved by the animal care committee of Nagoya City
University.
Sensitization procedures and allergen
challenge
We randomly assigned animals into the following three
groups: (i) naive (n = 6); (ii) saline-challenged (n = 9);
and (iii) OVA-challenged (n = 9). Rats of the saline- and
OVA-challenged groups were sensitized with intra-
peritoneal injections of 1 mg OVA (Sigma, Nagoya,
Japan), containing AI(OH)3 (100 mg/mL) in 0.9% saline,
on days 0 and 2 and then challenged with either 
exposure to aerosol of 0.9% saline or 1% OVA, respec-
tively, for 30 min on day 21. The naive group rats
(non-sensitized and non-challenged) were kept in identi-
cal conditions to the sensitized rats for 3 weeks and
studied thereafter at the same time points. The aerosol
was generated with a pumping nebulizer (Yagami,
Nagoya, Japan; particle size 1–10 m m, 5 L/min) con-
nected to a plexiglass exposure chamber with a volume
of 5L.
Urine collection
All groups of animals were kept in metabolic cages
(Chubu Science, Nagoya, Japan), which separate urine
from stools, from 1 day before the challenge with aerosol
to the end of the experiments. Urine samples were pooled
both for 0–24 h before and for 8–32 h after the challenge.
Bronchoalveolar lavage and cell counting
Bronchoalveolar lavages (BAL) were performed 32–36 h
after challenge with saline or OVA aerosol (between
10.00 and 14.00 h) to minimize the influence of any cir-
cadian rhythms on the parameters.
The abdominal cavity was incised under intraperitoneal
anesthesia with sodium pentobarbital (60 mg/100 g
weight). After blood was taken from the abdominal aorta,
the trachea was cannulated with a catheter. Ten milliliters
of Ca2+- and Mg2+-free phosphate-buffered saline (PBS)
with 5 mmol/L ethylenediaminetetraacetic acid (EDTA)
was instilled into the bronchoalveolar cavity and then
withdrawn. This procedure was repeated four times. After
BAL fluid (BALF) was collected, the lungs were removed,
weighed and kept in a – 40°C freezer until eosinophilic
peroxidase (EPO) activity was determined. The blood was
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centrifuged and the serum stored in a – 40°C freezer for
the subsequent analysis.
Cells in the BALF were sedimented by centrifugation
(10 min at 200 g, 4°C) and resuspended in PBS. Total
leukocyte counts were determined by autoanalyzer Model
F300 (Sysmex Toa, Tokyo, Japan). Macrophages,
eosinophils, neutrophils and lymphocytes in cytocen-
trifuge preparations were stained with Diff-Quick
(Kokusai shiyaku, Kobe, Japan). Cells were identified on
the basis of standard morphologic features. One thou-
sand cells were counted under 400-fold magnification.
The absolute and percentage numbers for each cell type
were determined.
Measurement of lung eosinophil
peroxidase activity
The lung (EPO) activity was measured as described by
Schneider and Issekutz.15 Approximately 300–400 mg
lung tissue (10–20% of the total lung) was homogenized
in 20 mmol/L potassium buffer (pH 7.4) containing
1 mmol/L EDTA and centrifuged at 6000 g for 20 min at
4°C. The pellet was rehomogenized in 50 mmol/L acetic
acid (pH 6.0) containing 0.5% cetyltrimethylammonium
hydroxide and sonicated for 10 s. The EPO activity in the
supernatant was then determined.
To determine EPO activity, aliquots were diluted 1/50
in 50 mmol/L HEPES pH 8.0, added to the EPO 
sub-strate solution, consisting of 50 mmol/L HEPES 
(pH 8.0), 6 mmol/L KBr, 3 mmol/L o-phenylene diamine,
4.5 mmol/L H202, and then incubated at 37°C for 3 min.
The reaction was stopped by adding 150 m L of 4 mol/L
H2SO4 and the absorbance at 490 nm was determined.
Measurement of urinary 11-OHCS
An aliquot of 4 mL urine was adjusted to pH 5.0 with
10% Na2CO3 and 2.4 mL pipetted into a glass-stop-
pered test tube, containing 0.4 mL acetate buffer and
2000 Fishman units of b -glucuronidase. After incubation
without a cap at 48°C for 15 h, 0.5 mL 0.25 mol/L
NaOH was added. The urine was shaken for about 40 s
with 5 mL methylene chloride and then centrifuged, the
urine layer removed by suction and the extract washed
with 0.1 mol/L NaOH in 1.0 mL 10% Na2SO4. After the
last wash, the extract was centrifuged and the aqueous
layer carefully removed. Aliquots of the extract (3 mL)
were pipetted into each of two test tubes, with 0.3 mL
ethanol. Phenylhydrazine-sulfuric acid solution (0.5 mL)
was added to one tube and 0.5 mL diluted sulfuric acid
to the other. After shaking for 30 s, the test tubes were
left for 15 min. The methylene chloride layer was then
removed by suction and the remaining phase incubated
in 60°C in a water bath for 30 min. During the incuba-
tion, the remaining methylene chloride vaporized. After
incubation, the optical densities of the samples against
blanks were measured at 410 nm in 10 mm cuvettes.
Measurement of urinary catecholamines
For the determination of free catecholamines, pooled
urine was collected in glass bottles containing 50 m L
6 mol/L HCL. Urinary epinephrine and norepinephrine
were measured by high-speed ion-exchange column
chromatography and fluorescence development with
trihydroxyindole.16
Hormone measurements
Serum corticosterone levels were determined using a
commercially available radioimmunoassay kit (coat-
A-count, Los Angeles, CA, USA). Plasma ACTH was
assayed immunoradiometrically employing a commercial
kit (Mediphysix, Tokyo, Japan).
Data analysis
Unless stated otherwise, group results are expressed as
mean ± SEM. Concentration–response curves were
tested with an analysis of variance (ANOVA, two-way).
Comparisons among the groups were performed with
one-way ANOVA using the STATVIEW data analysis system,
version 4.5 (Abacus Concepts, Inc., Berkeley, CA, USA).
Statistical significance was concluded at the 5% level of
confidence.
RESULTS
Bronchoalveolar lavage
Ovalbumin-challenged rats had significantly increased
total cell counts, including eosinophils and lymphocytes,
in BALF at 32–36 h after the challenge compared with
the naive and the saline-challenged rats (P < 0.0001,
P < 0.0001 and P < 0.05, respectively, Fig. 1). Eosino-
phil counts in BALF in the naive, saline-challenged and
OVA-challenged rats were 1.1 ± 0.8 · 10, 3.3 ± 1.2 ·
10 and 4.4 ± 0.2 · 102/m L, respectively. There were no
significant differences in the numbers of macrophages
and neutrophils in BALF among the three groups.
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Lung eosinophil peroxidase activity
Lung EPO activity at 32–36 h after the challenge signifi-
cantly increased in the OVA-challenged rats compared
with the naive and saline-challenged rats (2.93 ± 0.39
· 10–1 vs 0.94 ± 0.53 · 10–1 and 1.25 ± 0.24 · 10–1;
P < 0.01, Fig. 2).
Urinary 11-hydroxycorticosteroid excretion
Urinary 11-OHCS excretion for 8–32 h after the OVA
challenge significantly increased compared with the
values for 0–24 h before the challenge (P < 0.04,
Fig. 3a). The values before the challenge were 1.69 ±
0.1 · 10–1 and 1.79 ± 0.1 · 10–1 mg/g for the OVA-
and saline-challenged rats, respectively, and after the
challenge were 2.03 ± 0.1 · 10–1 and 1.74 ± 0.1 ·
10–1 mg/g, respectively.
Serum corticosterone and adrenocorticotropic
hormone levels
Serum corticosterone levels at 32–36 h after the chal-
lenge were significantly increased in the OVA-challenged
rats, compared with the naive and saline-challenged rats
(482 ± 49 vs 348 ± 19 and 341 ± 33 ng/mL, respec-
tively; P < 0.02 for both, Fig. 3b).
Serum ACTH levels at 32–36 h after challenge did not
significantly differ among the three groups, although the
values were slightly higher in the OVA-challenged rats
(data not shown).
Correlation between urinary 11-OHCS
excretion and serum corticosterone levels
There was a significant correlation between urinary
11-OHCS and serum corticosterone levels among the
values for the saline- and OVA-challenged rats
(r = 0.574, P < 0.01, n = 17; Fig. 4).
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Fig. 1 Numbers of total cells,
macrophages, neutrophils, eosino-
phils, and lymphocytes recovered
from bronchoalveolar lavage fluid
at 32–36 h after challenge in
the untreated (h; n = 6), saline-
challenge ( ; n = 9) and oval-
bumin-challenged Brown Norway
rats (j; n = 9). *P < 0.05 and
**P < 0.0001 compared with the
naive or saline-challenged rats.
Fig. 2 Lung eosinophil peroxidase (EPO) activity at 32–36 h
after challenge in the naive (h; n = 6), saline-challenged ( ;
n = 6) and ovalbumin (OVA)-challenged rats (j; n = 6).
Naive rats were untreated. *P < 0.01 compared with the naive
and saline-challenged rats.
Urinary epinephrine and norepinephrine
excretion
Urinary epinephrine and norepinephrine excretion before
and after challenge did not significantly differ among the
three groups (Table 1).
DISCUSSION
The present study clearly demonstrates that urinary 11-
OHCS and serum corticosterone levels are significantly
increased, whereas serum ACTH levels and urinary epi-
nephrine and norepinephrine excretion are not altered,
during allergen-induced eosinophilic inflammation in
BN rats.
The OVA aerosol challenge caused an increase in the
numbers of total cells and eosinophils in BALF and in
lung EPO activity, an indirect index of eosinophil infiltra-
tion into the lungs, at 32–36 h after challenge. Elwood
et al. have also reported a significant increase in
eosinophil recovery in BALF (i.e. airway inflammation)
both 5–8 h and 18–24 h after allergen challenge.14
Thus, the period from 8 to 36 h after the challenge can
be considered to coincide with eosinophilic inflammation
in this model.
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Fig. 3 (a) Urinary 11-hydroxycorticosteroid (OHCS) excretion in the naive (n = 6) rats and 0–24 h before (n = 9; h) and 8–32 h
after (n = 9; ) challenge in the saline- and ovalbumin (OVA)-challenged rats. *P < 0.04 compared with the saline-challenged
rats after challenge. †P < 0.05 compared with the OVA-challenged rats before challenge. (b) Serum corticosterone levels in the
naive rats (n = 6; h) and at 48 h after challenge in saline- (n = 8; ) and OVA-challenged rats (n = 8; j). *P < 0.02 compared
with the naive or saline-challenged rats.
Fig. 4 Correlation between urinary 11-hydroxycorticosteroid
(OHCS) excretion and serum corticosterone levels for the
saline- and ovalbumin-challenged rats (r = 0.574, n = 17).
Table 1 Effects of saline and ovalbumin challenge on the
urinary excretion of epinephrine  and norepinephrine in oval-
bumin-sensitized rats
OVA, ovalbumin.
Challenge Before After P value
Epinephrine Naive 4.70 ± 1.4
Saline 3.75 ± 0.56 4.31 ± 0.58 —
OVA 2.44 ± 0.78 3.48 ± 0.27 —
Norepinephrine Naive 52.1 ± 4.1
Saline 44.1 ± 9.4 51.9 ± 6.7 —
OVA 70.6 ± 10.1 50.7 ± 3.8 —
Because the adrenal glands of the rat lack the 17a -
hydroxylase that is needed to convert progesterone into
cortisol, corticosterone is the major endogenous cortico-
steroid and was therefore chosen for determination in the
present study. Diurnal variation is known to be substan-
tial, with the normal non-stressed serum corticosterone
level ranging from 50 ng/mL at approximately 6 h to a
peak of 400 ng/mL 12 h later.17 It would be ideal to con-
tinuously monitor the serum corticosterone levels during
the experimental period to assess the pituitary-adrenal
response in the rat, but this is impossible without inflicting
stresses. Previous studies have demonstrated that the
stress of tail shock caused increases in endogenous
ACTH and corticosterone levels in rats.8 We hypo-
thesized that animal handling, immobilization and
injection into the tail may have a profound influence 
on the animal’s pituitary-adrenal system. Therefore, we
assessed urinary 11-OHCS excretion, a main metabolite
of corticosterone, using metabolic cages during eosino-
philic inflammation and also measured serum corti-
costerone levels. Although we found a weak but signifi-
cant correlation between urinary 11-OHCS excretion
and serum corticosterone levels, measurement of urinary
11-OHCS excretion that reflects the amount of endoge-
nously secreted corticosterone may be particularly useful
and reliable.
In contrast to our findings, Durham et al. have
reported that serum cortisol levels at 3 h and 9 and 24 h
after allergen inhalation are virtually identical to those
observed with PBS in man, with no relationship to either
the size of the LAR or circulating eosinophil counts.11
Similarly, Nakazawa et al. have also investigated the
serum cortisol levels in two types of asthmatic response in
atopic patients with asthma and have found a slight
increase during the immediate response but a decrease
during LAR.10 They have speculated that LAR may be
caused by decreased synthesis of endogenous cortico-
steroids.10 The reason for this discrepancy is unclear.
However, we speculate that patients with asthma have a
more complex psychoneuroendocrine system and serum
cortisol responses than those encountered in a rat asthma
simple model.
Corticosteroids were originally thought to protect
organisms during periods of stress via an enhancement
of normal defense mechanisms.18,19 More recent studies
have demonstrated that corticosteroids act in a suppres-
sive manner, probably to protect against host defense
mechanisms activated by stress.20–22 Furthermore, it is
generally accepted that serum cortisol levels increase in
response to stress following stimulation of corticosteroid-
releasing factor and ACTH. However, serum ACTH levels
at 32–36 h after allergen inhalation were not significantly
increased in the present study. We think that the lack of
increase in serum ACTH may be explained by the previ-
ous finding that serum ACTH levels transiently increase
prior to the increase in corticosteroids and that ACTH is
metabolized very quickly in vivo.23 We speculate that
eosinophilic inflammation may cause certain types of
stress to the host and a consequent increase in serum
corticosterone. Thus, endogenous corticosterone may
increase as a pathophysiologic adrenal response to
protect the lung, although this is insufficient to suppress
eosinophilic inflammation. Our data do not support the
hypothesis that exhaustion of endogenous corticosterone
causes LAR in asthma.
Catecholamines are released into the circulation in
response to stress states, such as hypotension, hypoxia,
exercise and fear. High levels of both plasma epinephrine
and norepinephrine have been shown in life-threatening
illnesses, such as acute myocardial infarction, major
trauma and cardiac arrest. Norepinephrine is released
from sympathetic nerve terminals, while epinephrine and
dopamine are released from the adrenal medulla.24 It
has been demonstrated that norepinephrine levels are
increased, while epinephrine levels remain at normal
levels during acute moderate asthma in man.25 Similarly,
Parke et al. have reported that, despite clinically severe
respiratory obstructions, few patients had raised cate-
cholamine levels.26 This is generally consistent with our
findings, indicating that urinary epinephrine and norepi-
nephrine excretion are not increased in the present
model. Thus, we can speculate that catecholamines may
not increase beyond the physiologic range during acute,
mild or moderate asthma, whereas they may increase
during more severe asthma with circulatory failure and
the response governing endogenous secretion of epi-
nephrine and norepinephrine may be less sensitive than
that for corticosterone in this mild asthma model.
In conclusion, endogenous corticosterone, but not
epinephrine and norepinephrine, is increased during
antigen-induced eosinophilic airway inflammation in the
rat. Measurement of urinary levels of endogenous factors
appears to be a useful approach to assess pathophysio-
logic changes with minimal stress in asthma rats. Further
application of this method in the rat asthma model
should enable us to elucidate the roles of various types
of endogenous factors, including other hormones and
cytokines, during eosinophilic inflammation.
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